No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

COVID-19 has continued to alarm public health, and although several therapeutics and vaccines have been developed, the development of effective vaccines or antibodies is challenging due to mutations ...

More than five years since COVID was declared a pandemic, we're still facing the regular emergence of new variants of the ...

The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...

Australia is facing the regular emergence of new variants of the SARS-CoV-2 virus more than five years since Covid-19 was declared a pandemic. The latest variant – LP.8.1 – is on the rise, making up ...

Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...

The money is Wisconsin’s share of $12 billion approved by Congress to combat infectious disease and other serious health ...

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Federal cuts pull $200M from health grants, impacting public health preparedness and care in Colorado. State and local ...